title: [Treatment possibilities in breast cancer progressing after anthracyclines and/or taxanes].
abstract: The treatment of recurrent, progressing, metastatic breast cancer, which has previously been exposed to anthracyclines and/or taxanes is not only a major clinical challenge, but has a significant social impact too. In the absence of formal guidelines, this review has aimed to summarize the published evidence that is needed to guide clinical decision-making. Four new agents are approved for use in this setting: capecitabine, gemcitabine, ixabepilone, and nanoparticle albumin-bound paclitaxel. Nevertheless this review summarizes the results of studies with other active agents, as liposomal doxorubicin, rotation of taxanes, larotaxel, vinorelbine, and other biological agents.
authors.affiliation: XV. ker. Onkológiai Gondozó, Onkoradiológiai Központ, Budapest. nagykalnai.tamas@t-online.hu
authors.forename: Nagykálnai
authors.initials: N
authors.lastname: Tamás
authors.forename: Landherr
authors.initials: L
authors.lastname: László
authors.forename: Mészáros
authors.initials: M
authors.lastname: Edina
mesh_terms: D018943:Anthracyclines / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D018450:Disease Progression; D004317:Doxorubicin / Q000627:therapeutic use; D034261:Epothilones / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use; D016879:Salvage Therapy; D043823:Taxoids / Q000627:therapeutic use*; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D034261:Epothilones; D043823:Taxoids; D003841:Deoxycytidine; D014747:Vinblastine; D000069287:Capecitabine; D004317:Doxorubicin; C430592:ixabepilone; D017239:Paclitaxel; D000077235:Vinorelbine; C531079:larotaxel; D005472:Fluorouracil; D000093542:Gemcitabine